Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)

ConditionNeoplasm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNational Cancer Institute, Naples

About this trial

COESIT aims to establish a network of reference laboratories in the central-southern regions of Italy for the genetic and molecular characterization of tumors, with the goal of implementing precision and personalized oncology in clinical practice.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cancer patients

Patients from the central-southern regions

Disqualifiers

None

Trial population

Cancer patients from the central-southern regions of Italy diagnosed with lung, breast, colorectal, ovarian, liver, bile duct, pancreatic, and gastric cancers.

Trial design

Design model

Other

Time perspective

Other

Treatments tested in this trial

  • Creation of a laboratory network

    Other intervention

    Creation of a laboratory network in Central-Southern Italy capable of performing complex genomic analyses.

  • Mapping of genomic alterations

    Other intervention

    Mapping of genomic alterations aimed at precision medicine and personalized diagnostic and therapeutic approaches.

  • Creation of a bioinformatics network among the participating institutions.

    Other intervention

    Creation of a bioinformatics network among the participating institutions.

  • Development of a platform for the collection of clinicopathological and genetic-molecular data.

    Other intervention

    Development of a platform for the collection of clinicopathological and genetic-molecular data.

  • Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.

    Other intervention

    Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Improvement of diagnostic precision in oncology based on advanced molecular profiling tools.

Time frame
4 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.